Mercado Donar ahora Conviértase en Miembro

Carrito (0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Eventos globales

DoubleTree Bethesdan

23 sep 2019 7:00 a.m. - 24 sep 2019 5:00 p.m.

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Biosimilars Conference

Volver a Agenda

Session 2: The Pitfalls and Promises of Real World Evidence in Evolving the Biosimilar Industry

Session Chair(s)

Mark Stewart, PHD

Mark Stewart, PHD

Vice President, Science Policy, Friends of Cancer Research, United States

Anna Welch, MA

Anna Welch, MA

Chief Editor, Biosimilar Development, Life Science Connect, United States

Real world evidence has been a critical tool for reassuring stakeholders of the long-term safety and efficacy of biosimilars. But how else can RWE shape the evolving use of biologics and biosimilars? This panel will discuss the challenges of collecting and using RWE today to improve biosimilar understanding. It will also identify other areas of inquiry that can be addressed with RWE and the existing potential of RWE to evolve regulatory requirements and clinical treatment pathways.

Learning Objective : At the conclusion of this session, participants should be able to:
Evaluate current best-practices and challenges in RWE collection, analysis, and promotion
Assess evolving strategies for employing RWE in education
Discuss the impact RWE can have on pre-approval clinical data and the treatment pathway

Speaker(s)

Jaclyn Bosco, MPH, FISPE

Speaker

Vice President & General Manager, Global Head of Epidemiology & Scientific Strat, IQVIA, United States

Nancy Lin, DRSC, MS

Speaker

Senior Scientist, Epidemiology, Optum, United States

Speakers

Associate Director, HEOR & RWE, Sandoz, United States

Gianluca Trifiro, MD, PHD

Speaker

Scientific Lead, INSPIRE; Professor, Pharmacology, Diagnostics and Public Health, University of Verona, Italy

¿Tiene una cuenta?